This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
The first dengue NS3-NS4B inhibitor to enter the clinic. Recently disclosed in Nature, Janssen’s JNJ-1802 is the first dengue virus…
molecule
5 months ago ●
8 mins read
We did a deep dive into the pharmaceutical industry’s 2022Q2/Q3 news, and there’s a ton of exciting updates to share.…
Article
1 year ago ●
14 mins read
Upcycling a γ-secretase inhibitor for a potentially first- & best-in-class treatment for aggressive desmoid tumors. Nirogacestat was recently granted FDA…
molecule
5 months ago ●
8 mins read
Our team conducted a review of all the biotech acquisitions of 2021 and distilled it down to the acquisitions of…
Article
1 year ago ●
6 mins read
A Ph. II liver-targeting HBV core protein modulator optimized for ADMET properties. Linvencorvir (RG7907), a novel HBV core protein allosteric…
molecule
5 months ago ●
9 mins read
Amgen has acquired ChemoCentryx in a deal that includes lead molecule avacopan (Tavneos), a first-in-class orally bioavailable small molecule complement…
Article
1 year ago ●
5 mins read
Load More
